Dataset opportunity

Lipocoat — Regulatory Records Dataset Opportunity

Large regulatory records dataset held by Lipocoat, usable for Regulatory RAG and Compliance Copilots.

Regulatory Records DatasetTextRegulatory RAG🌍 Netherlandslipocoat.comOct 31, 2026

Confidence

65%

Market size (indicative estimate)

Global AI in Healthcare Regulatory Affairs market = $1.2B in 2024, CAGR 16.7%.

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

2 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • 🤝Data partnership

    Partnership with CEMMA Medical for coated CVC catheter validation

    source ↗
  • 📣Press / announcement

    Launch of UROCOAT project with Health~Holland for antibiotic-free catheter development

    source ↗

Profile

Dataset profile

Type

Regulatory Records Dataset

Modality

Text

Sector

healthcare

Volume

Large

Freshness

Periodic

Rarity

Medium

Accessibility

Partial

Legal

Owned by the company — licensing rights to clarify

Buyer persona

RegTech & compliance-AI vendors

Lipocoat holds a Regulatory Records Dataset in Text modality, containing proprietary chemical formulations, clinical trial data, and regulatory submissions evidence. This collection of structured and unstructured industrial_data is highly suitable for training a Regulatory RAG system to navigate complex compliance queries and accelerate product approval processes.

The value is underscored by the global AI in Healthcare Regulatory Affairs market, which reached $1.2B in 2024 and is projected to grow at a 16.7% CAGR. While access requires navigating IP sensitivities around proprietary chemical formulations and data tied to joint research with the University of Twente, the rarity and depth of this dataset offer a significant competitive advantage in the rapidly growing AI-driven compliance sector. ⚠ Diligence (valuable data, access to negotiate): Clinical trial data involves regulatory and privacy constraints; Proprietary chemical formulations are highly sensitive IP; Data is often tied to joint research with academic partners (University of Twente) · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence collectively proves Lipocoat holds specialized regulatory records and technical documentation detailing the biocompatibility evaluation of its medical coating technology against standards like ISO 10993-1. This text-based dataset is a prime asset for RegTech and compliance-AI vendors seeking to train or augment RAG systems for the complex healthcare sector. In a global AI in Healthcare Regulatory Affairs market projected to hit $1.2B in 2024 and grow at over 16% annually, this dataset offers a distinct competitive edge for automating compliance and product verification workflows.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit100

    ✓ good target — Lipocoat is an ideal target as it's an SME developing and manufacturing proprietary medical coatings, generating a significant amount of performance, testing, and regulatory data as a by-product of its core business, which it does not appear to be selling. Issues: The company helps its partners collect data for market approval and registration, which could be interpreted as a service, but their core product remains the ph

  • Deep Qualification90

    ✓ pass — Lipocoat is a strong data holder target. It develops and sells proprietary medical coatings, generating a by-product of valuable regulatory, clinical, and formulation data. Ownership is mixed due to extensive partnerships, and while no explicit resale restrictions were found, the data is sensitive (clinical/GDPR). A recent TFDA approval serves as a strong commercial trigger.

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Downloads / exports

The presence of downloadable product brochures and data sheets provides structured text on product specifications and marketing claims, which is essential for cross-referencing against regulatory submissions.

API access

Structured data on material composition and technical specifications, such as coating thickness and the absence of specific chemicals, offers verifiable inputs for automated compliance and safety assessments.

Regulatory records

Direct textual evidence confirms the technology has undergone biocompatibility testing according to ISO 10993-1, representing the core of the regulatory documentation valuable for training compliance models.

Image collection

Associated text from image collections details specific performance claims, such as enhanced ultrasound visibility, which are critical data points for verifying marketing against approved device capabilities.

Industrial data

The dataset includes longevity data from industrial performance testing, quantifying the coating's effectiveness against biofilm formation over time and providing crucial evidence for device durability claims.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://www.lipocoat.comingested
https://www.lipocoat.com/resources/documentsingested
https://www.lipocoat.com/resources/articles-and-eventsingested
https://www.lipocoat.com/resources/research-projectsingested
https://www.lipocoat.com/coating-technologies/lipocoat-platform-technologyingested
https://www.lipocoat.com/contactingested
https://www.lipocoat.cominferred

Deliverable

Premium dataset report

Lipocoat Regulatory Records — a Large regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in Healthcare Regulatory Affairs market = $1.2B in 2024, CAGR 16.7% (source: Transparency Market Research). Investment score 78.6/100 (confidence 0.65). Recommended action: License.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case